Production (Stage)
Channel Therapeutics Corporation
CHRO
$1.22
-$0.0065-0.53%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.97M | -1.93M | -1.69M | -1.77M | -2.56M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 94.20K | 76.10K | 10.30K | 0.00 | 605.60K |
| Total Other Non-Cash Items | 485.80K | 530.40K | 154.30K | 459.00K | 292.60K |
| Change in Net Operating Assets | 755.40K | 650.00K | 1.35M | -1.64M | -327.70K |
| Cash from Operations | -632.10K | -670.30K | -177.90K | -2.95M | -1.99M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 250.00K | -153.80K | -897.30K | 1.59M | -- |
| Total Debt Repaid | -- | 0.00 | 0.00 | 0.00 | -214.80K |
| Issuance of Common Stock | -- | 82.60K | 0.00 | 0.00 | 5.97M |
| Repurchase of Common Stock | -- | -75.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 75.00K | -75.00K | 0.00 | -91.50K |
| Cash from Financing | 250.00K | -71.20K | -972.30K | 1.59M | 5.67M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -382.10K | -741.50K | -1.15M | -1.37M | 3.67M |